title: [Standards, Options and Recommendations for the management of invasive cervical cancer patients (non metastastic)].
abstract: BACKGROUND
  The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of French Cancer Centers (FNCLCC), the 20 French cancer centers and specialists from French public university and general hospitals and private clinics. Its main objective is the development of clinical practice guidelines to improve the quality of health care and outcome for cancer patients. The methodology is based on literature review and critical appraisal by a multidisciplinary group of experts, with feedback from specialists in cancer care delivery.
  
  
  OBJECTIVE
  To develop, according to the definitions of the Standards, Options and Recommendations, clinical practice guidelines for the management of invasive cervical cancer patients. Methods : Data were identified by searching Medline and the personal reference lists of members of the expert groups, then submitted for review to independent reviewers.
  
  
  RESULTS
  This is a synthesis of the Standards, Options and Recommendations elaborated by a working group of experts. Pretherapeutic assessment, classification, diagnosis, therapeutic modalities (surgery, radiotherapy, radiochemotherapy, chemotherapy), therapeutic strategies by disease stage and follow-up are covered. Algorithms for the management of patients are also included.
authors.affiliation: FNCLCC, Standards, Options, Recommandations, 101, rue de Tolbiac, 75654 Paris cedex 13.
authors.forename: Michel
authors.initials: M
authors.lastname: Resbeut
authors.forename: Eric
authors.initials: E
authors.lastname: Fondrinier
authors.forename: Béatrice
authors.initials: B
authors.lastname: Fervers
authors.forename: Christine
authors.initials: C
authors.lastname: Haie-Meder
authors.forename: Anne
authors.initials: A
authors.lastname: Bataillard
authors.forename: Catherine
authors.initials: C
authors.lastname: Lhommé
authors.forename: Bernard
authors.initials: B
authors.lastname: Asselain
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Basuyau
authors.forename: Alain
authors.initials: A
authors.lastname: Brémond
authors.forename: Damienne
authors.initials: D
authors.lastname: Castaigne
authors.forename: Jean-Bernard
authors.initials: JB
authors.lastname: Dubois
authors.forename: Gilles
authors.initials: G
authors.lastname: Houvenaeghel
authors.forename: Eric
authors.initials: E
authors.lastname: Lartigau
authors.forename: Eric
authors.initials: E
authors.lastname: Leblanc
authors.forename: Xavier
authors.initials: X
authors.lastname: Sastre-Garau
authors.forename: Alice
authors.initials: A
authors.lastname: Sarradet
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Guastalla
authors.forename: Jean
authors.initials: J
authors.lastname: Chauvergne
mesh_terms: D000465:Algorithms; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D003127:Colposcopy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D001523:Mental Disorders / Q000523:psychology; D009367:Neoplasm Staging; D011379:Prognosis; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D012735:Sexual Dysfunction, Physiological / Q000523:psychology; D002583:Uterine Cervical Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents